about
Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidateChemical contaminants in breast milk and their impacts on children's health: an overviewComparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestinsDevelopment of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primatesEnvironmental exposures and developmentEffectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trialDabigatran, bleeding, and the regulatorsExposure to Hurricane Katrina, post-traumatic stress disorder and birth outcomes.Relationships of chemical concentrations in maternal and cord blood: a review of available data.Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.Modeling adverse environmental impacts on the reproductive system.Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHDAdvancing the selection of neurodevelopmental measures in epidemiological studies of environmental chemical exposure and health effectsTransplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate.Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes.Using systematic reviews and meta-analyses to support regulatory decision making for neurotoxicants: lessons learned from a case study of PCBsSimultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS)The effects of chronic methylphenidate administration on operant test battery performance in juvenile rhesus monkeys.Sex differences in drug disposition.A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES).Pharmacokinetics of oseltamivir among pregnant and nonpregnant women.Clinical therapeutics in pregnancy.Development and validation of a high-performance liquid chromatography-mass spectrometric assay for the determination of 17alpha-hydroxyprogesterone caproate (17-OHPC) in human plasma.Menstrual bleeding patterns among regularly menstruating women.A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometricsHepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytesSelected Proceedings of the NICHD/FDA newborn drug development initiative: Part II.Gaps in knowledge in treating pregnant women.Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons.The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settingsThe influence of sporadic anovulation on hormone levels in ovulatory cycles.The utility of menstrual cycle length as an indicator of cumulative hormonal exposureSerum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle studyClonidine pharmacokinetics in pregnancyAre we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practiceHuman decidual cell Toll-like receptor signaling in response to endotoxin: the effect of progestins.Environmental exposures and adverse pregnancy outcomes: a review of the science.
P50
Q23912198-24F3DCC0-83E4-4444-9CA8-D1B424F32481Q24816858-08201FD6-9BE6-4E97-9806-A48FE266B521Q28260077-C3C6230C-B707-450B-B832-D27F4DF3DD5CQ28393582-81D2B3AA-43B6-4B40-8C94-F15F3CEA069AQ28396215-4FD8ABDE-D2B3-4424-81C7-19A6DAE2DB9DQ29400587-2EA4D595-70A1-4D70-83D7-EEA84A96FE53Q30053694-2D67C480-D26B-41F5-85CE-C9C8893D992BQ30228793-D2A62AF4-56B7-40C4-A04E-1772E199A263Q30805001-08323220-AB16-49CA-A27A-74B077601CF8Q30841046-6FDB8672-D293-429F-ACC2-BFDC7C11AC40Q33547417-FFF9CF95-ED6A-4DA7-A77D-7B3FC95FB79EQ33594260-DD0F91DF-A36E-4EC5-A5DE-C52745421DAFQ33644261-02835CE5-1F01-4E8A-B562-86F6741554EFQ33714331-D31AED35-01DF-437E-B536-66DA6A476984Q33861905-BD2CEFD3-1E0D-4C2D-B340-936204C5CC3DQ33969178-3371DB95-5325-45B9-86F2-DC67A156219EQ34069524-E9085F4C-77EE-4E96-B620-E21F8E8503FCQ34140527-F6528A00-486A-47B4-946C-189E8619416BQ34635175-4DE312ED-2D78-411A-B282-2CEC389B17EAQ35028410-DE6B28A2-63FA-47BD-A720-988480178D23Q35036389-49DBF3EE-488A-4D45-AD10-B6E74A9E328EQ35113890-1E3E0E18-6053-4CCF-AA91-6C5A92DF5DC1Q35437948-92668F6F-F58F-49D7-BD73-47DDA79D1F6DQ35821775-3F10ABEB-3C82-42B2-8533-81A0BB4CC07EQ36406118-56CBDA30-45C3-464B-9271-9A1F8F3BC68EQ36431597-59504DDF-F510-4882-A13E-DB6FDC3C66A5Q36468109-8BFCB2BC-A71D-4AD0-AABE-95A9C28A9655Q36573335-9DE61A2D-3A5D-45FB-AAD7-062501E8A515Q36633549-BB79D87A-040B-4513-BCA1-A8797A7D5531Q36643247-31B29FC2-0344-4189-8B62-D70470017EAEQ36650851-A97AE41E-8A2E-410B-A8D4-856AB082C2E1Q36690963-A75A9930-3B57-45F9-8A94-FD97AA840E97Q36776322-A4F5FD8C-549C-4798-803C-7C095A1492ECQ36852654-51D2D855-CBCC-4E5C-BA7B-59533EDD33F1Q36906945-D6D22B5C-B0E2-4BA5-A92F-EA341803B395Q36936702-67AEFAA5-B70B-4DBE-A8AF-F8746FD377CEQ37188050-BC8E96F5-04DF-4093-B112-4B023F7D4EE6Q37198235-32CF4CAA-5B3D-4261-8BF3-32F74CFDB88EQ37266960-A8CD27D4-CB59-432C-8AF8-E7503EDC2723Q37286924-CAD98ECF-C730-4827-B974-705EC0272C32
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Donald Mattison
@ast
Donald Mattison
@en
Donald Mattison
@es
Donald Mattison
@nl
Donald Mattison
@sl
ডোনাল্ড ম্যাটিসন
@bn
type
label
Donald Mattison
@ast
Donald Mattison
@en
Donald Mattison
@es
Donald Mattison
@nl
Donald Mattison
@sl
ডোনাল্ড ম্যাটিসন
@bn
prefLabel
Donald Mattison
@ast
Donald Mattison
@en
Donald Mattison
@es
Donald Mattison
@nl
Donald Mattison
@sl
ডোনাল্ড ম্যাটিসন
@bn
P108
P1053
L-4661-2013
P106
P108
P1153
7005724234
P21
P31
P496
0000-0001-5623-0874